| __timestamp | Pharming Group N.V. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4042025 | 5496000 |
| Thursday, January 1, 2015 | 5279557 | 9786000 |
| Friday, January 1, 2016 | 8073913 | 6792000 |
| Sunday, January 1, 2017 | 44864073 | 7313000 |
| Monday, January 1, 2018 | 53488904 | 8382000 |
| Tuesday, January 1, 2019 | 65896361 | 10803000 |
| Wednesday, January 1, 2020 | 69968267 | 12944000 |
| Friday, January 1, 2021 | 92047281 | 21967000 |
| Saturday, January 1, 2022 | 131819000 | 32810000 |
| Sunday, January 1, 2023 | 87501000 | 46542000 |
In pursuit of knowledge
In the competitive world of biotechnology, managing Selling, General, and Administrative (SG&A) expenses is crucial for sustaining growth and innovation. This analysis compares the SG&A trends of Pharming Group N.V. and Xenon Pharmaceuticals Inc. from 2014 to 2023. Over this period, Pharming Group N.V. saw a staggering increase of over 2,000% in SG&A expenses, peaking in 2022. In contrast, Xenon Pharmaceuticals Inc. experienced a more modest rise of approximately 750%, with a notable surge in 2023. These trends reflect strategic shifts and market dynamics, with Pharming's aggressive expansion and Xenon's steady growth. Understanding these financial trajectories offers insights into each company's operational strategies and market positioning. As the biotech sector evolves, monitoring such financial metrics becomes essential for investors and stakeholders aiming to gauge future performance.
Who Optimizes SG&A Costs Better? Novo Nordisk A/S or Pharming Group N.V.
Comparing SG&A Expenses: Amgen Inc. vs Pharming Group N.V. Trends and Insights
Who Optimizes SG&A Costs Better? argenx SE or Pharming Group N.V.
Cost Management Insights: SG&A Expenses for Neurocrine Biosciences, Inc. and Xenon Pharmaceuticals Inc.
Breaking Down SG&A Expenses: Incyte Corporation vs Pharming Group N.V.
Who Optimizes SG&A Costs Better? Insmed Incorporated or Xenon Pharmaceuticals Inc.
Cost Management Insights: SG&A Expenses for Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.
Breaking Down SG&A Expenses: Pharming Group N.V. vs ImmunityBio, Inc.
Who Optimizes SG&A Costs Better? Pharming Group N.V. or Supernus Pharmaceuticals, Inc.
Axsome Therapeutics, Inc. and Xenon Pharmaceuticals Inc.: SG&A Spending Patterns Compared
Cost Management Insights: SG&A Expenses for Verona Pharma plc and Xenon Pharmaceuticals Inc.
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.